ConductScience.org, home
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
API referenceFor AI assistants

Trial · NCT01165281

Adverse events166

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 166

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets4168
otherAnaemiaBlood and lymphatic system disordersOxycodone Controlled-release (CR) Oral Tablets11172
otherConstipationGastrointestinal disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets51168
otherConstipationGastrointestinal disordersOxycodone Controlled-release (CR) Oral Tablets64172
otherDiarrhoeaGastrointestinal disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets9168
otherDiarrhoeaGastrointestinal disordersOxycodone Controlled-release (CR) Oral Tablets19172
otherNauseaGastrointestinal disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets48168
otherNauseaGastrointestinal disordersOxycodone Controlled-release (CR) Oral Tablets61172
otherVomitingGastrointestinal disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets41168
otherVomitingGastrointestinal disordersOxycodone Controlled-release (CR) Oral Tablets41172
otherDisease progressionGeneral disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets14168
otherDisease progressionGeneral disordersOxycodone Controlled-release (CR) Oral Tablets15172
otherMalaiseGeneral disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets6168
otherMalaiseGeneral disordersOxycodone Controlled-release (CR) Oral Tablets12172
otherPyrexiaGeneral disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets10168
otherPyrexiaGeneral disordersOxycodone Controlled-release (CR) Oral Tablets13172
otherDecreased appetiteMetabolism and nutrition disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets21168
otherDecreased appetiteMetabolism and nutrition disordersOxycodone Controlled-release (CR) Oral Tablets24172
otherSomnolenceNervous system disordersTapentadol (JNS024) Extended-release (ER) Oral Tablets29168
otherSomnolenceNervous system disordersOxycodone Controlled-release (CR) Oral Tablets36172

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01165281/events

API referenceFor AI assistants